Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology

Paula Aguilera

Dana Farber Cancer Institute
ONN

My career in oncology spans many years and includes roles in inpatient oncology, ambulatory oncology, community clinics as well as participation in several committees, with a special interest in improved access to care. I currently work for the Cancer Care Equity Program at Dana Farber Cancer Institute working to address the barriers that prevent patients from getting timely and equitable cancer care.